Aplastic anemia in systemic lupus erythematosus: A distinct presentation of acquired aplastic anemia?

Journal of Clinical Rheumatology

Volumn 7, Issue 6, 2001, Pages 377-383

  Tagoe, C ^a   Shah, A ^a   Yee, H ^a   Belmont, H M ^a  

^a NYU HOSPITAL FOR JOINT DISEASES   (United States)

Author keywords

Aplastic anemia; Bone marrow; Systemic lupus erythematosus

Indexed keywords

AZATHIOPRINE; ERYTHROPOIETIN; HYDROXYCHLOROQUINE; METHYLPREDNISOLONE; PREDNISONE;

ADULT; APLASTIC ANEMIA; ARTICLE; BLOOD TRANSFUSION; BONE MARROW BIOPSY; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC APPROACH ROUTE; DISEASE COURSE; FEMALE; HUMAN; HUMAN TISSUE; MALE; PANCYTOPENIA; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0035216948     PISSN: 10761608     EISSN: None     Source Type: Journal    
DOI: 10.1097/00124743-200112000-00006     Document Type: Article

References (30)

1. Aplastic anaemia-aetiology and clinical features
2. Severe major organ involvement in systemic lupus erythematosus. Diagnosis and management
3. Plasmapheresis in active systemic lupus erythematosus: Effects on clinical, serum, and cellular abnormalities. Case report
4. Reversal of aplastic anaemia secondary to systemic lupus erythematosus by high-dose intravenous cyclophosphamide
5. Aplastic anemia complicating systemic lupus erythematosus: Response to androgens in two patients
6. An antibody that inhibits in vitro bone marrow proliferation in a patient with systemic lupus erythematosus and aplastic anemia
7. Aplastic anaemia in systemic lupus erythematosus: A cellular immune mechanism?
8. Aplastic anemia associated with systemic lupus erythematosus
9. Aplastic anemia in neonatal lupus erythematosus
10. Aplastic anemia as the sole presentation of systemic lupus erythematosus
11. Inhibition of hematopoiesis by a plasma factor in a case of aplastic anemia associated with systemic lupus erythematosus
12. Mortality studies in systemic lupus erythematosus. Results from a single center. III. Improved survival over 24 years
13. Reduction in circulating dsDNA antibody titer after administration of LJP 394
14. Serum inhibitor in systemic lupus erythematosus associated with aplastic anemia
15. Serum inhibitors of hematopoiesis in a patient with aplastic anemia and systemic lupus erythematosus. Recovery after exchange plasmapheresis
16. Subsets of patients with aplastic anemia identified by flow microfluorometry
17. Circulating activated suppressor T lymphocytes in aplastic anemia
18. Long-term bone marrow cultures in aplastic anaemia
19. The pathophysiology of acquired aplastic anemia
20. Immune pathophysiology of acquired aplastic anaemia
21. High-dose intravenous cyclophosphamide treatment of systemic lupus erythematosus-associated aplastic anemia
22. New York University/Hospital for Joint Diseases experience with intravenous cyclophosphamide treatment: Efficacy in steroid unresponsive lupus nephritis
23. Complete remission in severe aplastic anemia after high-dose cyclophosphamide without bone marrow transplantation
24. 4-Hydroperoxycyclophosphamide inhibits proliferation by human granulocyte-macrophage colony-forming cells (GM-CFC) but spares more primitive progenitor cells
25. Immunoablative high-dose cyclophosphamide without stem-cell rescue for refractory, severe autoimmune disease
26. Oral cyclosporin-A is effective treatment for untreated and also for previously immunosuppressed patients with severe bone marrow failure
27. Antithymocyte globulin for a patient with systemic lupus erythematosus complicated by severe pancytopenia
28. Primary treatment of acquired aplastic anemia: Outcomes with bone marrow transplantation and immunosuppressive therapy
29. Severe aplastic anemia: A prospective study of the effect of early marrow transplantation on acute mortality
30. Results of transplanting bone marrow from genetically identical twins into patients with aplastic anemia [see comments]